Market

AI Model Rates Redfin And Carvana Top Short Today

After Tuesday’s sharp market reversal for tech stocks and the Dow’s worst one-day decline since February, more pain was on the horizon on Wednesday for anxious investors. Why? Inflation is no longer a debate- it’s authentic, and it’s here. Based on the Consumer Price Index, inflation in April spiked at its fastest pace since 2008. The Consumer Price Index spiked 4.2% from a year ago, compared to Dow Jones
DOW
estimates of 3.6%. Meanwhile, the monthly gain was 0.8% compared to the expected 0.2%. As a result, the Dow Jones continued its sell-off and fell more than 150 points, the S&P 500 lost 0.6%, and the Nasdaq
NDAQ
dipped more than 1%. Big Tech led the declines on the day, while financials and energy stocks were the relative outperformers. If you’re looking for a way to play this market, the deep learning algorithms at Q.ai have crunched the data to give you a set of Top Shorts. Our Artificial Intelligence (“AI”) systems assessed each firm on parameters of Technicals, Growth, Low Volatility Momentum, and Quality Value to find the best short plays. 

Sign up for the free Forbes AI Investor newsletter here to join an exclusive AI investing community and get premium investing ideas before markets open.

Amyris Inc (AMRS)

Amyris Inc is today’s first Top Short. Amyris Inc.
AMRS
is a synthetic biotechnology and renewable chemical company. It serves the specialty and performance chemicals, flavors and fragrances, cosmetics ingredients, pharmaceuticals, and nutraceuticals markets. Our AI systems rated the company F in Technicals, D in Growth, D in Low Volatility Momentum, and D in Quality Value. The stock closed up 1.14% to $11.57 on volume of 5,350,483 vs its 10-day price average of $13.39 and its 22-day price average of $14.39, and is up 64.81% for the year. Revenue grew by 85.32% in the last fiscal year and grew by 404.47% over the last three fiscal years, Operating Income grew by -101.07% in the last fiscal year and grew by -101.0% over the last three fiscal years, and EPS grew by -31.64% over the last three fiscal years. Revenue was $173.14M in the last fiscal year compared to $63.6M three years ago, Operating Income was $(123.42)M in the last fiscal year compared to $(132.72)M three years ago, and EPS was $(1.88) in the last fiscal year compared to $(3.69) three years ago.  

MORE FROM FORBESAmyris (AMRS)

Blink Charging Co (BLNK) 

Blink Charging Co is our next Top Short today. Blink Charging Co provides fast, level 2 EV Charging Stations and Networks for both homes and businesses. Our AI systems rated the company D in Technicals, F in Growth, F in Low Volatility Momentum, and C in Quality Value. The stock closed up 3.15% to $31.08 on volume of 3,292,584 vs its 10-day price average of $34.6 and its 22-day price average of $35.77, and is down 17.13% for the year. Revenue was $6.23M in the last fiscal year compared to $2.69M three years ago, Operating Income was $(17.39)M in the last fiscal year compared to $(11.61)M three years ago, EPS was $(0.59) in the last fiscal year compared to $(1.3) three years ago, and ROE was (103.16%) in the last year. 

MORE FROM FORBESBlink Charging (BLNK)

Carvana Co (CVNA)

Carvana is our third Top Short. The company is a major innovator and disruptor in the car industry, and is a robust online used car dealer. Our AI systems rated Carvana C in Technicals, F in Growth, D in Low Volatility Momentum, and F in Quality Value. The stock closed down 1.23% to $239.19 on volume of 2,323,676 vs its 10-day price average of $272.0 and its 22-day price average of $274.2, and is up 1.24% for the year. Revenue grew by 20.53% in the last fiscal year and grew by 244.35% over the last three fiscal years, Operating Income grew by -23.77% in the last fiscal year, and EPS grew by -22.3% in the last fiscal year. Revenue was $5586.56M in the last fiscal year compared to $1955.47M three years ago, Operating Income was $(332.4)M in the last fiscal year compared to $(220.73)M three years ago, EPS was $(2.63) in the last fiscal year compared to $(2.03) three years ago, and ROE was (93.05%) in the last year compared to (100.5%) three years ago. Forward 12M Revenue is also expected to grow by 5.25% over the next 12 months.

MORE FROM FORBESCarvana (CVNA)

Redfin Corp (RDFN)

Our fourth Top Short for the day is Redfin Corp
RDFN
. Redfin is a Seattle-based real estate brokerage, and operates with a unique business model. With Redfin’s business model, sellers pay Redfin a small fee to list the seller’s home, in addition to another small fee charged to the seller to compensate the brokerage representing the buyer. Customers who buy with Redfin are only charged 1% to list their home, and also receive a portion of the brokerage’s commission back (called the Redfin Refund). Our AI systems rated Redfin D in Technicals, F in Growth, C in Low Volatility Momentum, and D in Quality Value. The stock closed down 2.52% to $54.25 on volume of 2,083,674 vs its 10-day price average of $62.71 and its 22-day price average of $64.76, and is down 19.32% for the year. Revenue grew by 8.73% in the last fiscal year and grew by 97.86% over the last three fiscal years, Operating Income grew by 313.59% in the last fiscal year and grew by -168.8% over the last three fiscal years, EPS grew by -95.82% in the last fiscal year and grew by -98.01% over the last three fiscal years. Revenue was $886.09M in the last fiscal year compared to $486.92M three years ago, Operating Income was $7.31M in the last fiscal year compared to $(43.93)M three years ago, EPS was $(0.23) in the last fiscal year, compared to $(0.49) three years ago, and ROE was (3.85%) in the last year compared to (13.82%) three years ago. Forward 12M Revenue is also expected to grow by 6.77% over the next 12 months.

MORE FROM FORBESRedfin (RDFN)

Reata Pharmaceuticals Inc (RETA) 

Our final Top Short for the day is Reata Pharmaceuticals Inc
RETA
.  Reata Pharmaceuticals is a pharmaceutical company primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs. Our AI systems rated the company D in Technicals, D in Growth, D in Low Volatility Momentum, and F in Quality Value. The stock closed down 2.01% to $83.06 on volume of 510,373 vs its 10-day price average of $93.55 and its 22-day price average of $92.5, and is down 31.52% for the year. Operating Income grew by -5.5% in the last fiscal year. Revenue was $9.02M in the last fiscal year compared to $53.59M three years ago, Operating Income was $(226.32)M in the last fiscal year compared to $(76.88)M three years ago, EPS was $(7.35) in the last fiscal year, compared to $(2.91) three years ago, and ROE was (73.49%) in the last year. 

MORE FROM FORBESReata Pharmaceuticals (RETA)

Liked what you read? Sign up for our free Forbes AI Investor Newsletter here to get AI driven investing ideas weekly. For a limited time, subscribers can join an exclusive slack group to get these ideas before markets open.

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button